Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV

NCT05020899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2024-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of this two arm randomized clinical trial (RCT) is to test if a smoking cessation program called Quit for Life (QFL) which was developed by the investigators is effective for patients in China with HIV who smoke. This program is designed to suit the needs of people with HIV who smoke in China.

Eligible participants who provide consent will be randomized into either the QFL or the Control group.

The QFL group will receive a quit smoking program that lasts for 8 weeks with two parts-

1. 4 sessions with a trained counselor who will discuss the participants' smoking habits and strategies to help them quit.
2. Messages sent to the participants' cell phone using WeChat.

The Control group will not have sessions with a trained counselor or receive messages sent to their cell phone.

Both groups will be offered nicotine replacement therapy and a self-help guide with information about quitting smoking.

Conditions

  • Smoking Cessation
  • HIV Infections

Interventions

BEHAVIORAL

Sessions with a trained counselor

4 sessions will be provided with a trained counselor who will discuss the participant's' smoking habits with them and strategies to help them quit. The first session is in-person, lasts for 20 minutes, and typically happens when the participant comes to the HIV clinic to pick up their medication. Sessions 2 through 4 are over the telephone and last for 15 minutes each. These occur 1 week, 4 weeks, and 8 weeks after the first session.

OTHER

Cell phone messages

Brief messages that give tips to help quit smoking will be sent to participants' cell phones using WeChat. 3 messages per day will be sent for the first week, 2 messages per day for the next 3 weeks, 1 message per day for the next 1 week, and 1-2 messages per week for the rest of the time

OTHER

Offered nicotine replacement therapy

Participants will be offered nicotine replacement therapy (gum or patch, depending on which one is available).

OTHER

Self-help guide for quitting smoking

Participants will be offered a self-help guide with information about quitting smoking.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Lisa Quintiliani, PhD · Boston Medical Center

  • Hao Liang, PhD · Guangxi Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • United States
  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05020899 on ClinicalTrials.gov